Catalog
Client
Theme:
0 0
Catalog
Main page
Wishlist
0
Compare
0
Contacts

Humalog Kwikpen 100IU/ml Eli Lilly

Brand: Eli Lilly Product Code: EU11250
0
All about product
Description
Specification
Reviews 0
Questions0
Humalog Kwikpen 100IU/ml Eli Lilly
Out Of Stock
€241.00
Acne: No
Active substance: Insulin Lispro
Also known as: Exogenous insulin
Aromatization: No
Blood pressure: Can indirectly affect blood pressure by altering blood glucose levels
Humalog Kwikpen 100IU/ml Eli Lilly
Humalog Kwikpen 100IU/ml Eli Lilly
€241.00
Description
Specifications
Features
Acne
No
Active substance
Insulin Lispro
Also known as
Exogenous insulin
Aromatization
No
Blood pressure
Can indirectly affect blood pressure by altering blood glucose levels
Chemical name
Insulin
Classification
hormone and synthetic substitute / antidiabetic agent
Dosage (medical)
Depends on the patient's insulin sensitivity, carbohydrate intake, and blood glucose level, typically ranges from 0.5 to 1 unit/kg per day
Dosage (sports)
Not recommended for non-medical use
Effects
Decreases blood glucose, increases cellular glucose uptake, promotes glycogen synthesis
Formula
C257H383N65O77S6 (for human insulin)
Half-life
Varies by type (Rapid-acting: 2-4 hours, Short-acting: 3-6 hours, Intermediate-acting: 12-18 hours, Long-acting: 20-24 hours)
HBR
No
Hepatotoxicity
No
Lab Test
Blood insulin levels, C-peptide test
Main action
Lowers blood glucose levels
Side effects
Hypoglycemia, weight gain, insulin resistance, allergic reactions
Storage conditions
Must be kept refrigerated (2-8 degrees Celsius), avoid freezing
Substance class
Hormone, peptide
Trade name
Humulin, Novolin, Lantus, among others
Use in sports
Misused for anabolic purposes
WAREHOUSE
International Warehouse 2
Water Retention
No
Manufacturer
Lilly
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.